pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,031 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 43 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,338
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT03295227: Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Stage III Thymoma AJCC v8, Stage IIIA Thymoma AJCC v8, Stage IIIB Thymoma AJCC v8, Stage IV Thymoma AJCC v8, Stage IVA Thymoma AJCC v8, Stage IVB Thymoma AJCC v8, Unresectable Thymic Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06905561: Topical Diclofenac for Prevention of Radiation-induced Dermatitis

Sponsor: The Second Affiliated Hospital of Hainan Medical University. Phase: NA. Conditions: Head and Neck Tumor, Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07526961: Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland

Sponsor: Bristol-Myers Squibb. Phase: . Conditions: Non-Small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07325461: Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes

Sponsor: Tandem Diabetes Care, Inc.. Phase: NA. Conditions: Diabetes Mellitus, Type 1

full page →ctgov ↗
›RECRUITINGphase readoutNCT04864886: Metabolic Profiling of Immune Responses in Immune-mediated Diseases

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Primary Immunodeficiency, Psoriasis, Atopic Dermatitis, Immune-mediated Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT07447570: Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: PHASE2. Conditions: Head and Neck Cancer, Radiotherapy, Anti-PD-1/CTLA-4 Antibody

full page →ctgov ↗
›RECRUITINGphase readoutNCT07326670: Effects of Spinal vs General Anesthesia on Systemic Inflammation in PCNL

Sponsor: Elazıg Fethi Sekin Sehir Hastanesi. Phase: . Conditions: Anesthesia Techniques, Percutaneous Nephrolithotomy, Systemic Inflammation

full page →ctgov ↗
›RECRUITINGphase readoutNCT06991270: OMNI 3.1 Surgical System in Subjects With Primary Open-Angle Glaucoma

Sponsor: Sight Sciences, Inc.. Phase: NA. Conditions: Primary Open Angle Glaucoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06397573: Ablative Stereotactic MR-Guided Adaptive Reirradiation

Sponsor: Baptist Health South Florida. Phase: NA. Conditions: Abdominal Cancer, Pelvic Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05010473: Cortical Contributions to Frequency Following Responses and Modulation

Sponsor: Northwestern University. Phase: NA. Conditions: Language

full page →ctgov ↗
›RECRUITINGphase readoutNCT06609473: Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors

Sponsor: Dana-Farber Cancer Institute. Phase: NA. Conditions: Childhood Cancer, Childhood Cancer Survivors

full page →ctgov ↗
›COMPLETEDphase readoutNCT05411341: Comparison of Two Different Optical Biometric Systems

Sponsor: Democritus University of Thrace. Phase: . Conditions: Cataract, Presbyopia, Ocular Biometry, Intraocular Lens

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01580241: Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer

Sponsor: University of Oklahoma. Phase: . Conditions: Pancreatic Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07225283: Developing Resiliency and Exercise Using AI-based Messaging

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Diabetes Mellitus Type 2

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07506954: Impact of Sound Shower Music Diffusion on Family Anxiety in Intensive Care Unit Waiting Room

Sponsor: University Hospital, Tours. Phase: NA. Conditions: Anxiety

full page →ctgov ↗
›RECRUITINGphase readoutNCT06588166: Microbiome Testing for the Screening of Colorectal Cancer

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: Colorectal Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07477366: Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma

Sponsor: ImmunityBio, Inc.. Phase: PHASE2. Conditions: Relapsed B-Cell Non-Hodgkin Lymphoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT03438994: Early Assessment of Autism Through Smart Tablet Gameplay

Sponsor: University of Strathclyde. Phase: NA. Conditions: Autism Spectrum Disorder, Other Neurodevelopmental Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07518966: Association Between Early Recurrence and Long-Term Recurrence After Pulsed Field Ablation for Atrial Fibrillation: Prospective Real-World Evidence From China

Sponsor: West China Hospital. Phase: . Conditions: Atrial Fibrillation (AF)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07226817: A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants

Sponsor: Bristol-Myers Squibb. Phase: PHASE1. Conditions: Healthy Volunteers

full page →ctgov ↗
›COMPLETEDphase readoutNCT07426640: Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature Ejaculation

Sponsor: Al Mouwasat Hospital. Phase: NA. Conditions: Premature (Early) Ejaculation

full page →ctgov ↗
›COMPLETEDphase readoutNCT01675440: Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement

Sponsor: Medtronic Cardiovascular. Phase: . Conditions: Severe Aortic Stenosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06854640: A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy

Sponsor: Bayer. Phase: PHASE1. Conditions: Sepsis, Coagulopathy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05261750: Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer

Sponsor: PT. Prodia Stem Cell Indonesia. Phase: PHASE1. Conditions: Nasopharyngeal Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03971591: Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors

Sponsor: Medical College of Wisconsin. Phase: NA. Conditions: Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05766891: Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06455774: The Wearable Postural Feedback Devices Combined With Exercise in Office Workers With Chronic Neck Pain

Sponsor: Istanbul University - Cerrahpasa. Phase: NA. Conditions: Neck Pain

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07161518: Characterizing Transcranial Focused Ultrasound Neuromodulation During Sedation

Sponsor: Stanford University. Phase: PHASE4. Conditions: Healthy Participants

full page →ctgov ↗
›RECRUITINGphase readoutNCT07264790: Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Recon

Sponsor: Duke University. Phase: PHASE1. Conditions: Breast Reconstruction, Perfusion; Complications, High Risk for Breast Cancer, Genetic Predisposition

full page →ctgov ↗
›RECRUITINGphase readoutNCT05848713: AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

Sponsor: University of Manitoba. Phase: PHASE3. Conditions: Community-acquired Pneumonia

full page →ctgov ↗
›COMPLETEDphase readoutNCT03839459: Denosumab for Smoldering Multiple Myeloma

Sponsor: University of Rochester. Phase: PHASE2. Conditions: Smoldering Multiple Myeloma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT05651880: Efficacy and Tolerance of Baricitinib, a JAK Inhibitor, in the Treatment of Refractory Non-infectious Non-anterior Uveitis

Sponsor: University Hospital, Rouen. Phase: PHASE3. Conditions: Active Non-anterior Non-infectious Uveitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07431879: Acute Muscle Damage After Eccentric Quasi-Isometric Exercise of the Elbow Flexors

Sponsor: Chinese Culture University. Phase: NA. Conditions: Acute Muscle Damage Following Resistance Exercise

full page →ctgov ↗
›RECRUITINGphase readoutNCT06519162: Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome

Sponsor: Chungnam National University Hospital. Phase: . Conditions: Autoimmune Hepatitis, Primary Sclerosing Cholangitis, Non-Alcoholic Fatty Liver Disease, Liver Abscess, Primary Biliary Cirrhosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT04810546: Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy

Sponsor: University of Illinois at Chicago. Phase: NA. Conditions: Iron-deficiency, Pregnancy Anemia, Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07062588: Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)

Sponsor: Angitia Incorporated Limited. Phase: PHASE2. Conditions: Osteogenesis Imperfecta (OI)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07503288: Genotype and Subtype Mapping of the Hepatitis C Virus

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Hepatitis C Virus, Mutation Abnormality, RNA Positive, Unusual Subtype, Resistance

full page →ctgov ↗
›COMPLETEDphase readoutNCT07427888: Treatment of Cancer Pain Using an Implantable Intrathecal Pump

Sponsor: Institute of Oncology Ljubljana. Phase: NA. Conditions: Cancer Pain, Neoplasm-Related Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07069127: Hydroxyapatite-Based Home Treatment for Dentin Sensitivity in Celiac Patients

Sponsor: University of Pavia. Phase: NA. Conditions: Celiac Disease, Dentin Hypersensitivity, Tooth Demineralization

full page →ctgov ↗
›WITHDRAWNphase readoutNCT04977427: Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes

Sponsor: Baylor Research Institute. Phase: PHASE4. Conditions: Cataract Diabetic, Macula Edema

full page →ctgov ↗
›COMPLETEDphase readoutNCT07548970: Identification and Characterization of At-risk MASLD in Turkish Adults

Sponsor: Maastricht University Medical Center. Phase: . Conditions: MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease), Mediterranean Diet, Lifestyle (Sedentary Behavior and Physical Activity), Vitamin D Deficiency, Hyperuricemia and MAFLD, Ferritin

full page →ctgov ↗
›COMPLETEDphase readoutNCT03621670: Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants

Sponsor: GlaxoSmithKline. Phase: PHASE3. Conditions: Infections, Meningococcal

full page →ctgov ↗
›COMPLETEDphase readoutNCT06653673: The Effect of a ChatGPT-Supported Online Group-Guided Self-Help Program on Uncontrolled and Emotional Eating Behaviors and Body Image in Overweight and Obese Woman Nurses

Sponsor: Dokuz Eylul University. Phase: NA. Conditions: Overweight (BMI > 25), Obesity and Overweight, Emotional Eating, Binge Eating

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07507669: Impact of MetaCalm on Stress of Healthy People With Acute Stress

Sponsor: Metagenics, Inc.. Phase: NA. Conditions: Adults, Acute Stress Reaction

full page →ctgov ↗
›RECRUITINGphase readoutNCT06497569: Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer

Sponsor: H. Lee Moffitt Cancer Center and Research Institute. Phase: NA. Conditions: GastroEsophageal Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06801483: Ankle Strengthening in Athletes With Chronic Ankle Instability

Sponsor: China Medical University Hospital. Phase: NA. Conditions: Chronic Ankle Instability, CAI, Athletes

full page →ctgov ↗
›RECRUITINGphase readoutNCT05465941: PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Sponsor: Mayo Clinic. Phase: PHASE2. Conditions: Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, Stage IV Fallopian Tube Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Primary Peritoneal Cancer AJCC v8

full page →ctgov ↗
›COMPLETEDphase readoutNCT06799741: A Study to Evaluate the Safety and Efficacy of AV-1 Against Dengue Virus 3 (DENV-3) Infection

Sponsor: AbViro LLC. Phase: PHASE2. Conditions: DENV-3 Controlled Human Infection Model

full page →ctgov ↗
›RECRUITINGphase readoutNCT06638541: Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions

Sponsor: Royal Marsden NHS Foundation Trust. Phase: NA. Conditions: Prostate Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07388641: Improving Productive Community Integration in Homeless-experienced Veterans

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Homeless Persons

full page →ctgov ↗
← prev
page 61 of 161
next →